NO167287C - Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.

Info

Publication number
NO167287C
NO167287C NO883833A NO883833A NO167287C NO 167287 C NO167287 C NO 167287C NO 883833 A NO883833 A NO 883833A NO 883833 A NO883833 A NO 883833A NO 167287 C NO167287 C NO 167287C
Authority
NO
Norway
Prior art keywords
beta
isoxazol
preparation
carbolines
therapeutic active
Prior art date
Application number
NO883833A
Other languages
English (en)
Other versions
NO167287B (no
NO883833D0 (no
NO883833L (no
Inventor
Andreas Huth
Dieter Rahtz
Ralph Rohde
Ralph Schmiechen
Dieter Seidelmann
Herbert Hans Schneider
David Norman Stephens
John Bondo Hansen
Mogens Engelstoft
Preben Olsen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK449887A external-priority patent/DK449887D0/da
Priority claimed from DE19873730667 external-priority patent/DE3730667A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO883833D0 publication Critical patent/NO883833D0/no
Publication of NO883833L publication Critical patent/NO883833L/no
Publication of NO167287B publication Critical patent/NO167287B/no
Publication of NO167287C publication Critical patent/NO167287C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO883833A 1987-08-28 1988-08-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner. NO167287C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK449887A DK449887D0 (da) 1987-08-28 1987-08-28 Beta-carbolinderivater, deres fremstilling og anvendelse
DE19873730667 DE3730667A1 (de) 1987-09-09 1987-09-09 Neue ss-carboline

Publications (4)

Publication Number Publication Date
NO883833D0 NO883833D0 (no) 1988-08-26
NO883833L NO883833L (no) 1989-03-01
NO167287B NO167287B (no) 1991-07-15
NO167287C true NO167287C (no) 1991-10-23

Family

ID=25859709

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883833A NO167287C (no) 1987-08-28 1988-08-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.

Country Status (15)

Country Link
US (1) US4933345A (no)
EP (1) EP0305322B1 (no)
JP (1) JP2690329B2 (no)
AU (1) AU619203B2 (no)
CA (1) CA1324382C (no)
DE (1) DE3888428D1 (no)
ES (1) ES2061716T3 (no)
FI (1) FI88160C (no)
HU (1) HU203101B (no)
IE (1) IE65712B1 (no)
IL (1) IL87563A (no)
NO (1) NO167287C (no)
NZ (1) NZ225959A (no)
PT (1) PT88351B (no)
RU (1) RU1836369C (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US5543519A (en) * 1991-06-15 1996-08-06 Schering Aktiengesellschaft 3-aryl or 3-hetaryl-β-carbolines, their production and use in pharmaceutical agents
DE4120109A1 (de) * 1991-06-15 1992-12-17 Schering Ag 3-aryl- oder 3-hetaryl-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
JP3108483B2 (ja) * 1991-09-30 2000-11-13 日清製粉株式会社 インドール誘導体およびこれを有効成分とする抗潰瘍薬
DE4330175A1 (de) * 1993-08-31 1995-03-02 Schering Ag Alkoxy-substituierte beta-Carboline
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
FR2953838B1 (fr) * 2009-12-10 2012-02-24 Sanofi Aventis Derives de 9h-beta-carboline (ou 9h-pyridino[3,4-b]indole) trisubstitues, leur preparation et leur utilisation therapeutique
FR2953837B1 (fr) * 2009-12-10 2012-03-09 Sanofi Aventis Derives 9h-pyridino[3,4-b]indole disubstitues, leur preparation et leur utilisation therapeutique
US10947253B2 (en) 2019-08-05 2021-03-16 Ankh Life Sciences Limited Fused polycyclic dimers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3240513A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Indolderivate, verfahren zu ihrer herstellung und deren verwendung zur weiterverarbeitung
DE3240511A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von ss-carbolinderivaten
DE3240514A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3322895A1 (de) * 1983-06-23 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ss-carboline, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel (s)
DK240084D0 (da) * 1984-05-15 1984-05-15 Ferrosan As New beta-carboline-3-oxadiazolyl derivatives
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
NZ225959A (en) 1991-02-26
NO167287B (no) 1991-07-15
DE3888428D1 (de) 1994-04-28
FI88160B (fi) 1992-12-31
FI883963A (fi) 1989-03-01
IL87563A (en) 1993-08-18
AU619203B2 (en) 1992-01-23
IL87563A0 (en) 1989-01-31
IE65712B1 (en) 1995-11-15
EP0305322A2 (de) 1989-03-01
PT88351A (pt) 1989-06-30
IE882600L (en) 1989-02-28
CA1324382C (en) 1993-11-16
US4933345A (en) 1990-06-12
JPS6468370A (en) 1989-03-14
RU1836369C (ru) 1993-08-23
NO883833D0 (no) 1988-08-26
FI883963A0 (fi) 1988-08-26
EP0305322B1 (de) 1994-03-16
NO883833L (no) 1989-03-01
EP0305322A3 (en) 1990-04-04
HUT48244A (en) 1989-05-29
FI88160C (fi) 1993-04-13
ES2061716T3 (es) 1994-12-16
HU203101B (en) 1991-05-28
JP2690329B2 (ja) 1997-12-10
PT88351B (pt) 1995-03-31
AU2150088A (en) 1989-03-02

Similar Documents

Publication Publication Date Title
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO171787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO884473D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO881762D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO884698L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO881190D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 9- (beta-d-deoxyribofuranosyl)-mucleosider.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO882201D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.